P
ProteinQure
Biotech & Life Sciences · Toronto, Canada · Founded 2017
Computational protein design MoreLess
ProteinQure is a biotechnology company specializing in the computational design of peptides for precise tissue-specific therapeutic delivery. Operating in the precision medicine market, ProteinQure serves pharmaceutical companies and research institutions looking to enhance the efficacy of their treatments while minimizing side effects. The company's proprietary peptides are designed to deliver therapeutic payloads directly to disease-inducing cells via receptor-mediated endocytosis, ensuring targeted treatment. ProteinQure's business model revolves around partnerships and collaborations with pharmaceutical firms, generating revenue through licensing agreements and milestone payments. By leveraging a cross-disciplinary team of experts in Experimental Biology, Software Engineering, Machine Learning, and Computational Biology, ProteinQure aims to transform drug development and offer new hope to patients with previously untreatable diseases.
Keywords: computational peptides, tissue-specific delivery, precision medicine, therapeutic payloads, receptor-mediated endocytosis, drug discovery, biotechnology, pharmaceutical partnerships, targeted treatment, cross-disciplinary team.
Company overview
ProteinQure company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2017
- Headquarters
- Toronto, Canada
- Employees
- 32
- Open positions
- None listed
- Dealroom signal
- 67.9
Valuation & funding
ProteinQure funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | May 2026 | $1.3M | — | FedDev Ontario | ↗ |
| GRANT✓Other financing | Apr 2026 | $1.9M | — | Genome Canada · Ontario Genomics | ↗ |
| SERIES A✓Equity / VC | May 2025 | $11M | $44M | Golden Ventures · Kensington Capital Partners · Heron Rock Fund | ↗ |
| DEBT✓Debt | Feb 2024 | $513K | — | Government of Canada | ↗ |
| SEED✓Equity / VC | Jul 2019 | $4M | $16M | 8VC · Global Founders Capital · Tom Williams · Inovia Capital | — |
| SEEDEquity / VC | Jul 2018 | Undisclosed | — | ||
| SUPPORT PROGRAM✓Other financing | Dec 2017 | Google for Startups Accelerator | — | ||
| SEEDEquity / VC | Nov 2017 | Creative Destruction Lab | — | ||
| SPINOUT✓Other financing | Oct 2017 | University of Toronto | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $1.4M | 0% | 32 |
| 2025 | $1.4M | 0% | 32 |
| 2024 | $1.4M | 0% | 26 |
| 2023 | $1.4M | 0% | 20 |
| 2022 | $1.4M | +12.5% | 19 |
| 2021 | $1.2M | — | 18 |
| 2020 | — | — | 16 |
Growth signals
ProteinQure website traffic
Latest recorded traffic for ProteinQure is 7.9K monthly website visits, up 41.1% over the last three months. ProteinQure's team grew 0% over the past year.
Comparisons
ProteinQure compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
ProteinQure's talent
Source: Dealroom Talent Intelligence.
Investors
18 investors on ProteinQure's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where ProteinQure has talent and traffic
team presence
In the news
Latest news about ProteinQure
Recent press, funding announcements, and product moves mentioning ProteinQure — open to read from the original sources.
Market sentiment
What the market is saying about ProteinQure
An AI-synthesized read of the highest-engagement posts about ProteinQure on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ProteinQure’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.